A further large-scale, translational study for LAG-3 expression in TNBC is warranted to confirm the role of tumor-intrinsic LAG-3 expression in mTNBC treated with PD-1/PD-L1 inhibitors. The gene discussed is CD274; the disease is neoplasm.